Dr. Casey Peavler

Website

Dr. Casey Peavler 🩺 Board-certified Internal Medicine M.D.
🌱 Functional Medicine | Metabolic & Mitochondrial Oncology Education Casey Peavler is a Medical Doctor (M.D.)

who is Board Certified in Internal Medicine. Dr. Peavler has specialized training in integrative, functional, and mitochondrial medicine. He practices hospitalist medicine in South Florida. He is also the Owner and Medical Director of Integra Functional Internal Medicine. He is interested in mitochondrial function, mitochondrial dysfunction, cancer, cancer as a mitochondrial metabolic disease, cancer as a metabolic disease, ketogenic metabolic therapy, metabolic therapy, photobiomodulation, integrative medicine, functional medicine, nutrition, biohacking, and quantum biology. Press-Pulse Implementation Lab: https://www.skool.com/press-pulse-implementation-lab-3118/about

10/23/2026

Understanding how prostate cancer creates new fats under hypoxic conditions is crucial. It utilizes acetyl-CoA carboxylase and fatty acid synthase, not for fuel, but for new fat production. This distinction is often misunderstood.

10/22/2026

Elevated STAT3 levels can reduce sensitivity to certain therapies. Conversely, downregulating STAT3 might increase therapy sensitivity. SLC1A5, a key glutamine transporter, plays a role in this process. We also observe decreases in glucose uptake and glutamine metabolism.

10/21/2026

Silymarin and silibinin from milk thistle target cancer cells at numerous levels. By affecting growth factors, cytokines, and key transcription factors like STAT3 and HIF1 alpha, they disrupt metabolic reprogramming essential for cancer cell survival and growth. This approach shows significant potential in metabolic interventions.

10/20/2026

Blocking STAT3 with milk thistle could increase therapy response and decrease glucose/glutamine metabolism. High STAT3 levels show the opposite effects.

10/19/2026

Exploring how silibinin, combined with EGFR TKIs, could impact non-small cell lung cancer. Silibinin shows promise in suppressing EGFR signaling, affecting key pathways like PI3/AKT/mTOR, STAT3, and RAF/MEK/ERK, which are crucial for tumor growth and resistance.

10/18/2026

Did you know milk thistle can significantly improve blood glucose and glucose ketone index? Studies show routine silymarin administration leads to a notable reduction in fasting blood glucose and HbA1c levels. This research highlights its potential for managing Type 2 Diabetes.

10/17/2026

A new paper explores how Silibinin combats triple-negative breast cancer by modulating the tumor's immune microenvironment. It suppresses PD-L1 expression, reduces inflammation, and targets cancer cells to enhance oxidative stress.

10/17/2026

Recent studies show silymarin significantly reduces fasting blood glucose and A1c levels. Updated meta-analyses confirm notable reductions in blood pressure, cholesterol, triglycerides, and insulin, with A1c dropping by up to 1.25%.

10/16/2026

Scientists discover how a compound disrupts redox adaptations by targeting a key axis, enhancing oxidative stress specifically in cancer cells. This breakthrough offers new hope for treating triple-negative breast cancer. Pathway

10/15/2026

Milk thistle is known for liver support, but its compounds like silibinin are showing fascinating effects on cancer pathways. Research suggests it impacts metabolism, inflammation, and survival, going beyond just antioxidant properties. Let's explore what it's doing inside cancer cells.

Address

Miramar, FL
Miramar, FL

Website

Alerts

Be the first to know and let us send you an email when Dr. Casey Peavler posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category